Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.120
-0.030 (-2.61%)
Jun 10, 2026, 10:29 AM EDT - Market open
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $48.2 million as of June 10, 2026. Its market cap has increased by 33.27% in one year.
Market Cap
48.20M
Enterprise Value
47.56M
1-Year Change
33.27%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $48.20M, an increase of 2,611.43%. That is a compound annual growth rate of 147.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 48.63M | -17.46% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 50.12M |
| Immutep | 50.02M |
| Dogwood Therapeutics | 48.77M |
| Tevogen Bio Holdings | 48.74M |
| Mereo BioPharma Group | 48.68M |
| Metagenomi Therapeutics | 48.56M |
| Veru Inc. | 48.15M |
| Lantern Pharma | 47.85M |